BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fukami Y, Kaneoka Y, Maeda A, Kumada T, Tanaka J, Akita T, Kubo S, Izumi N, Kadoya M, Sakamoto M, Nakashima O, Matsuyama Y, Kokudo T, Hasegawa K, Yamashita T, Kashiwabara K, Takayama T, Kokudo N, Kudo M;  Liver Cancer Study Group of Japan. Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey. Ann Surg. 2020;272:145-154. [PMID: 30672806 DOI: 10.1097/sla.0000000000003192] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Orimo T, Kamiyama T, Kakisaka T, Nagatsu A, Asahi Y, Aiyama T, Kamachi H, Taketomi A. Hepatectomy is Beneficial in Select Patients with Multiple Hepatocellular Carcinomas. Ann Surg Oncol. [DOI: 10.1245/s10434-022-12495-z] [Reference Citation Analysis]
2 Risaliti M, Bartolini I, Campani C, Arena U, Xodo C, Adotti V, Rosi M, Taddei A, Muiesan P, Amedei A, Batignani G, Marra F. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis. World J Gastroenterol 2022; 28(29): 3981-3993 [DOI: 10.3748/wjg.v28.i29.3981] [Reference Citation Analysis]
3 Kokudo T, Ishizawa T, Nagata R, Ichida A, Mihara Y, Kawaguchi Y, Akamatsu N, Kaneko J, Arita J, Kokudo N, Hasegawa K. Optimal tumor numbers in surgical candidates for multiple hepatocellular carcinomas. Surgery 2022. [DOI: 10.1016/j.surg.2022.06.019] [Reference Citation Analysis]
4 Wang P, Zhang D, Fang C, Gan Y, Luo B, Yang XL, Peng FY, Li B, Su S. Partial hepatectomy vs. transcatheter arterial chemoembolization for multiple hepatocellular carcinomas of BCLC-B stage: A meta-analysis of high-quality studies. Eur J Surg Oncol 2022:S0748-7983(22)00412-7. [PMID: 35545472 DOI: 10.1016/j.ejso.2022.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cassese G, Han H, Lee B, Lee HW, Cho JY, Troisi R. Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma. Cancers 2022;14:2012. [DOI: 10.3390/cancers14082012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang Y, Liao A, Pu X, Yang J, Lv T, Yan L, Yang J, Wu H, Jiang L. A randomized controlled trial of effect of 15- or 25-minute intermittent Pringle maneuver on hepatectomy for hepatocellular carcinoma. Surgery 2021:S0039-6060(21)01150-8. [PMID: 34916072 DOI: 10.1016/j.surg.2021.11.012] [Reference Citation Analysis]
7 Reig M, Forner A, Rimola J, Ferrer-Fábrega J, Burrel M, Garcia-Criado A, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. J Hepatol 2021:S0168-8278(21)02223-6. [PMID: 34801630 DOI: 10.1016/j.jhep.2021.11.018] [Cited by in Crossref: 156] [Cited by in F6Publishing: 132] [Article Influence: 156.0] [Reference Citation Analysis]
8 Yamamoto M, Kobayashi T, Honmyo N, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka Y, Ohdan H. Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology. Surgery 2021:S0039-6060(21)00891-6. [PMID: 34756748 DOI: 10.1016/j.surg.2021.09.009] [Reference Citation Analysis]
9 Taketomi A. Hepatic Resection for Hepatocellular Carcinoma in the Era of Molecular-targeted Agents and Immune Checkpoint Inhibitors in Japan. JMA J 2021;4:241-5. [PMID: 34414318 DOI: 10.31662/jmaj.2021-0035] [Reference Citation Analysis]
10 Romano F, Chiarelli M, Garancini M, Scotti M, Zago M, Cioffi G, De Simone M, Cioffi U. Rethinking the Barcelona clinic liver cancer guidelines: Intermediate stage and Child-Pugh B patients are suitable for surgery? World J Gastroenterol 2021; 27(21): 2784-2794 [PMID: 34135554 DOI: 10.3748/wjg.v27.i21.2784] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kudo M. Surveillance, Diagnosis, and Treatment Outcomes of Hepatocellular Carcinoma in Japan: 2021 Update. Liver Cancer 2021;10:167-80. [PMID: 34239807 DOI: 10.1159/000516491] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Fukami Y, Saito T, Osawa T, Arikawa T, Matsumura T, Kurahashi S, Komatsu S, Kaneko K, Sano T. Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma. Med Princ Pract 2021;30:131-7. [PMID: 33361696 DOI: 10.1159/000514031] [Reference Citation Analysis]
13 Lee SY, Ahn CS, Yoon YI, Lee SG, Hwang S, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park GC. Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients. Ann Hepatobiliary Pancreat Surg. 2020;24:437-444. [PMID: 33234746 DOI: 10.14701/ahbps.2020.24.4.437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Iida H, Kaibori M, Hirokawa F, Inoue Y, Ueno M, Matsui K, Ishizaki M, Tanaka S, Takemura S, Nomi T, Hokutou D, Noda T, Eguchi H, Nakai T, Maehira H, Mori H, Tani M, Kubo S. New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study. Asian Pac J Cancer Prev 2020;21:2903-11. [PMID: 33112547 DOI: 10.31557/APJCP.2020.21.10.2903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep. 2020;2:100134. [PMID: 32695968 DOI: 10.1016/j.jhepr.2020.100134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
16 Lei Y, Yee LW, Zhou WP. Multiple hepatocellular carcinomas: liver resection or transcatheter arterial chemoembolization? Hepatobiliary Surg Nutr 2019;8:519-21. [PMID: 31673544 DOI: 10.21037/hbsn.2019.05.13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Zaydfudim VM, Adams RB. Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma. Hepatobiliary Surg Nutr 2019;8:543-5. [PMID: 31673553 DOI: 10.21037/hbsn.2019.04.12] [Reference Citation Analysis]
18 Viganò L, Costa G, Di Tommaso L. Liver resection for multifocal hepatocellular carcinoma: is it an option? Hepatobiliary Surg Nutr 2019;8:530-3. [PMID: 31673548 DOI: 10.21037/hbsn.2019.05.12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]